“Thymic carcinoma is a rare cancer with poor prognosis after recurrence, and there is a need for new treatment options. We are working to obtain approval so that Tecentriq that demonstrated favourable ...

Amidst the continued struggle to treat non-small-cell lung cancer, a new study led by Stanford University scientists suggests that a patient's response to immunotherapy may hinge on how immune cells ...

Manufacturing CAR T cells in the laboratory is expensive and time-consuming. An in vivo approach could get the powerful ...

ILC accounts for 10–15% of breast cancers and often goes undetected. Learn about its characteristics, treatments, and future ...

Credit: NIAID In the early 1960s, Professor Jaques Miller discovered the essential role of the thymus in our immune systems while working as a PhD student at The Institute of Cancer Research in London ...

Researchers found that the Wnt5a protein, secreted by inflammatory fibroblasts within cancerous tumors, inhibits angiogenesis and consequently promotes hypoxia within tumors. Hypoxic conditions help ...

as well as continuing refinements in molecular pathology and imaging. The increased personalisation of cancer therapy, introduction of multidisciplinary treatment approaches, and widespread adoption ...

AACE released clinical guidelines on the diagnosis, management, and surveillance of tumors related to multiple endocrine neoplasia type 1.

Complete Pathologic Response reported in 2 patients in the Third Cohort with cutaneous squamous cell carcinoma, complementing results in prior cohort Marlborough, Massachusetts--(Newsfile Corp ...

The Centre for Molecular Pathology is a collaborative initiative between The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, aiming to identify the molecular mechanisms that ...

Mariana Chavez MacGregor, MD, MSc, shares her enthusiasm for the 2025 ASCO Annual Meeting, particularly for its relevance to early-stage breast cancer. She highlights key sessions focused on ...